Association between striae gravidarum and pelvic floor dysfunction symptoms during pregnancy.


Journal

International urogynecology journal
ISSN: 1433-3023
Titre abrégé: Int Urogynecol J
Pays: England
ID NLM: 101567041

Informations de publication

Date de publication:
12 2022
Historique:
received: 08 04 2022
accepted: 12 05 2022
pubmed: 7 6 2022
medline: 19 11 2022
entrez: 6 6 2022
Statut: ppublish

Résumé

Striae gravidarum are linear atrophic scars appearing on the abdomen of pregnant women reported to be related to pregnancy-induced changes in the connective tissue. Pelvic floor distress symptoms are also known to be linked to connective tissue weakness. Given that common pathophysiological pathways may play a role in both striae gravidarum and pelvic floor dysfunction symptoms, we sought to examine whether there is a correlation between them during pregnancy. A prospective observational study among third-trimester pregnant women who visited a tertiary medical center for routine pregnancy follow-up was conducted by using the Pelvic Floor Distress Inventory (PFDI-20) questionnaire to evaluate pelvic floor distress symptoms and the Davey method for evaluating striae gravidarum severity. Obstetrical characteristics as well as pelvic floor distress symptoms were compared between two groups according to the severity of striae gravidarum. Univariate analysis was carried out using appropriate tests; PFDI scores were compared between the groups using the Mann-Whitney test. Women with striae gravidarum were significantly older (31.06 vs. 28.83 years, p < 0.01), had a lower body mass index (27.5 vs. 30.98, p < 0.01), and gave birth to smaller neonates (3155 vs. 3389 g, p < 0.01). In addition, the overall and median PFDI-20 scores differed between the groups (with severe SG having the highest median score of 20 and those with milder SG having a score of 16 compared to 14 in those without SG). A distinct association between the PFDI-20 score and SG severity was not demonstrated (p = 0.63). In our population, an association was demonstrated between pelvic floor distress symptoms and the presence of striae gravidarum. However, following a linear regression model, no statistically significant association between SG severity and total PFD-20 score was seen. Our findings strengthen the hypothesis of common connective tissue involvement in the pathophysiology of both conditions.

Identifiants

pubmed: 35666288
doi: 10.1007/s00192-022-05249-8
pii: 10.1007/s00192-022-05249-8
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3441-3447

Informations de copyright

© 2022. The International Urogynecological Association.

Références

Fitzpatrick TB. (Thomas B, Freedberg IM. Fitzpatrick’s Dermatology in General Medicine. McGraw-Hill, Medical Pub. Division; 2003. https://www.ncbi.nlm.nih.gov/nlmcatalog/101141765 . Accessed 4 Oct 2017.
Gabbe SG. Obstetrics: Normal and Problem Pregnancies. Elsevier/Saunders; 2012.
Poidevin LO. Striae gravidarum. Their relation to adrenal cortical hyperfunction. Lancet (London, England). 1959;2(7100):436-439. http://www.ncbi.nlm.nih.gov/pubmed/14433675 . Accessed 4 Oct 2017.
Yamaguchi K, Suganuma N, Ohashi K. Quality of life evaluation in Japanese pregnant women with striae gravidarum: A cross-sectional study. BMC Res Notes. 2012;5(1):450. https://doi.org/10.1186/1756-0500-5-450 .
doi: 10.1186/1756-0500-5-450 pubmed: 22905939 pmcid: 3503700
Ghasemi A, Gorouhi F, Rashighi-firoozabadi M, Jafarian S, Firooz A. Striae gravidarum: Associated factors. J Eur Acad Dermatol Venereol. 2007;21(6):743–6. https://doi.org/10.1111/j.1468-3083.2007.02149.x .
doi: 10.1111/j.1468-3083.2007.02149.x pubmed: 17567300
Kasielska-Trojan A, Sobczak M, Antoszewski B. Risk factors of striae gravidarum. Int J Cosmet Sci. 2015;37(2):236–40. https://doi.org/10.1111/ics.12188 .
doi: 10.1111/ics.12188 pubmed: 25440082
Osman H, Rubeiz N, Tamim H, Nassar AH. Risk factors for the development of striae gravidarum. Am J Obstet Gynecol. 2007;196(1):62.e1–5. https://doi.org/10.1016/j.ajog.2006.08.044 .
doi: 10.1016/j.ajog.2006.08.044
Davey CM. Factors associated with the occurrence of striae gravidarum. J Obstet Gynaecol Br Commonw. 1972;79(12):1113-1114. http://www.ncbi.nlm.nih.gov/pubmed/4646568 . Accessed 4 Oct 2017.
Yohay D, Weintraub AY, Mauer-Perry N, et al. Prevalence and trends of pelvic floor disorders in late pregnancy and after delivery in a cohort of Israeli women using the PFDI-20. Eur J Obstet Gynecol Reprod Biol. 2016;200:35–9. https://doi.org/10.1016/j.ejogrb.2016.02.037 .
doi: 10.1016/j.ejogrb.2016.02.037 pubmed: 26967344
Salter SA, Batra RS, Rohrer TE, Kohli N, Kimball AB. Striae and pelvic relaxation: two disorders of connective tissue with a strong association. J Invest Dermatol. 2006;126(8):1745–8. https://doi.org/10.1038/sj.jid.5700258 .
doi: 10.1038/sj.jid.5700258 pubmed: 16557237
Lee KS, Rho YJ, Jang SI, Suh MH, Song JY. Decreased expression of collagen and fibronectin genes in striae distensae tissue. Clin Exp Dermatol. 1994;19(4):285–8 http://www.ncbi.nlm.nih.gov/pubmed/7955466 . Accessed October 4, 2017.
doi: 10.1111/j.1365-2230.1994.tb01196.x pubmed: 7955466
Watson RE, Parry EJ, Humphries JD, et al. Fibrillin microfibrils are reduced in skin exhibiting striae distensae. Br J Dermatol. 1998;138(6):931-937. http://www.ncbi.nlm.nih.gov/pubmed/9747352 . Accessed 4 Oct 2017.
DTY L. STRIÆ GRAVIDARUM. Lancet. 1974;303(7858):625. https://doi.org/10.1016/S0140-6736(74)92681-6 .
doi: 10.1016/S0140-6736(74)92681-6
Spellacy E. Urinary incontinence in pregnancy and the puerperium. J Obstet Gynecol neonatal Nurs JOGNN. 30(6):634–41 http://www.ncbi.nlm.nih.gov/pubmed/11724199 . Accessed 20 Oct 2017.
Pardo E, Rotem R, Glinter H, et al. Recovery from pelvic floor dysfunction symptoms in the postpartum is associated with the duration of the second stage of labor. Arch Gynecol Obstet. 2019;300(1):127–33. https://doi.org/10.1007/s00404-019-05173-1 .
doi: 10.1007/s00404-019-05173-1 pubmed: 31053946
Ward RM, Velez Edwards DR, Edwards T, Giri A, Jerome RN, Wu JM. Genetic epidemiology of pelvic organ prolapse: A systematic review. Am J Obstet Gynecol. 2014;211(4):326–35. https://doi.org/10.1016/j.ajog.2014.04.006 .
doi: 10.1016/j.ajog.2014.04.006 pubmed: 24721264 pmcid: 4213176
Wong MY, Harmanli OH, Agar M, Dandolu V, Grody MHT. Collagen content of nonsupport tissue in pelvic organ prolapse and stress urinary incontinence. Am J Obstet Gynecol. 2003;189(6):1597–9; discussion 1599-1600. https://doi.org/10.1016/j.ajog.2003.09.043 .
doi: 10.1016/j.ajog.2003.09.043 pubmed: 14710077
Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol. 2005;193(1):103–13. https://doi.org/10.1016/j.ajog.2004.12.025 .
doi: 10.1016/j.ajog.2004.12.025 pubmed: 16021067
Ahmed AA, Taha OT, Elprince M. Evaluation of the severity of striae gravidarum in women with pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol. 2020;253:21–4. https://doi.org/10.1016/j.ejogrb.2020.07.029 .
doi: 10.1016/j.ejogrb.2020.07.029 pubmed: 32745816
Ren P, Zhao W, Dai X, et al. Risk factors for the formation of striae gravidarum in women in Jiangsu Province of China. 2019. https://doi.org/10.1016/j.tjog.2019.07.010
Farahnik B, Park K, Kroumpouzos G, Murase J. Striae gravidarum: Risk factors, prevention, and management. Int J Women’s Dermatol. 2017;3(2):77–85. https://doi.org/10.1016/j.ijwd.2016.11.001 .
doi: 10.1016/j.ijwd.2016.11.001
Gul R, Iqbal S, Anwar Z, Ahdi SG, Ali SH, Pirzada S. Pre-pregnancy maternal BMI as predictor of neonatal birth weight. PLoS One. 2020;15(10 October). https://doi.org/10.1371/journal.pone.0240748 .
Halperin O, Raz I, Ben-Gal L, Or-Chen K, Granot M. Prediction of perineal trauma during childbirth by assessment of striae gravidarum score. JOGNN-J Obstet Gynecol Neonatal Nurs. 2010;39(3):292–7. https://doi.org/10.1111/j.1552-6909.2010.01137.x .
doi: 10.1111/j.1552-6909.2010.01137.x
Lipschuetz M, Cohen SM, Israel A, et al. Sonographic large fetal head circumference and risk of cesarean delivery. Am J Obstet Gynecol. 2018;218(3):339.e1–7. https://doi.org/10.1016/J.AJOG.2017.12.230 .
doi: 10.1016/J.AJOG.2017.12.230

Auteurs

Yael Lichtman (Y)

Department of Obstetrics and Gynecology, Soroka Medical Center, Beer-Sheva, Israel.

Amir Horev (A)

Pediatric Dermatology Services, Soroka Medical Center, Beer-Sheva, Israel. amirhr@clalit.org.il.
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. amirhr@clalit.org.il.

Tamar Matyashov (T)

Department of Obstetrics and Gynecology, Soroka Medical Center, Beer-Sheva, Israel.

Reut Rotem (R)

Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Affiliated with the Hebrew University Medical School of Jerusalem, 12 Bayit Street, 91031, Jerusalem, Israel.

Maayan Elnir Katz (ME)

Department of Obstetrics and Gynecology, Soroka Medical Center, Beer-Sheva, Israel.

Tamar Eshkoli (T)

Department of Obstetrics and Gynecology, Soroka Medical Center, Beer-Sheva, Israel.

Adi Y Weintraub (AY)

Department of Obstetrics and Gynecology, Soroka Medical Center, Beer-Sheva, Israel.
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH